Sacubitril And Valsartan Tablet, Film Coated
Product Images NDC 73190-007

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sacubitril And Valsartan (NDC 73190-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

180 (005 18)

Packaging label for Sacubitril and Valsartan Tablets, 24 mg/26 mg strength. The film-coated tablets are labeled for oral use and come in a bottle of 180 tablets. The label shows the AvKARE logo with NDC 73190-005-18 and includes storage instructions and manufacturer details for AvKARE and MSN Pharmaceuticals Inc.*

FDA Label Image

60 (005 60)

Label for Sacubitril and Valsartan Tablets by AvKARE, showing strength of 24 mg sacubitril and 26 mg valsartan per film-coated tablet. The package contains 60 tablets. The label includes storage instructions, manufacturer information, and a barcode.*

FDA Label Image

180 (006 18)

Label for Sacubitril and Valsartan Tablets 49 mg/51 mg by AvKARE. The film-coated tablet packaging indicates 180 tablets per container. The label includes storage instructions, manufacturing details by MSN Pharmaceuticals Inc., and notes the prescription-only status.*

FDA Label Image

60 (006 60)

Sacubitril and Valsartan Tablets 49 mg/51 mg film-coated tablets in a carton labeled for 60 tablets. The label shows the AvKARE logo and states the product is Rx only. It includes storage instructions, manufacturing details, and dosage strength.*

FDA Label Image

180 (007 18)

Sacubitril and Valsartan Tablets 97 mg/103 mg film-coated oral tablets. The label shows a package of 180 tablets, marked Rx Only, manufactured for AvKARE and by MSN Pharmaceuticals Inc. Storage instructions and dosage guidance references are included on the label.*

FDA Label Image

60 (007 60)

Sacubitril and Valsartan 97 mg/103 mg film-coated tablets packaging label. The label shows the product name, strength, quantity of 60 tablets, and indicates prescription use only. It is labeled by AvKARE and includes storage instructions and manufacturer information from MSN Pharmaceuticals Inc.*

FDA Label Image

Figure-1 (Sacubitril Valsartan Figure 1)

A forest plot chart showing the geometric mean ratio and 90% confidence intervals for the pharmacokinetic parameters AUC and Cmax of various coadministered drugs relative to a reference. Drugs listed include Furosemide, Warfarin, Digoxin, Carvedilol, Levonorgestrel, Ethinyl estradiol, Amlodipine, HCTZ, Metformin, Atorvastatin, and Sildenafil, with data points displayed as filled circles for AUC and open circles for Cmax.*

FDA Label Image

Figure-2 (Sacubitril Valsartan Figure 2)

A comparative chart depicting the geometric mean ratios and 90% confidence intervals for the pharmacokinetic parameters AUC and Cmax of sacubitril (LBQ657) and valsartan under various population conditions. The chart compares changes relative to reference values across categories including renal impairment severity, hepatic impairment severity, age groups, sex, and race.*

FDA Label Image

Sacubitril-valsartan-figure-3.jpg (Sacubitril Valsartan Figure 3)

Three Kaplan-Meier survival curve charts labeled Figure A, B, and C show cumulative failure rate (%) over time since randomization (days) comparing Sacubitril and Valsartan with Enalapril. Figure A depicts time to first occurrence of cardiovascular death or heart failure hospitalizations, Figure B shows time to occurrence of cardiovascular death, and Figure C shows time to first occurrence of heart failure hospitalizations in the PARADIGM-HF study. Each chart includes number at risk tables and hazard ratio (HR) values with confidence intervals.*

FDA Label Image

Structure (Sacubitril Valsartan Structure)

Chemical structure diagram showing the molecular structure of Sacubitril and Valsartan, the active ingredients in the medication Sacubitril and Valsartan tablets.*

FDA Label Image

Sacubitril-valsartanl-figure-4.jpg (Sacubitril Valsartanl Figure 4)

A forest plot displaying hazard ratios with 95% confidence intervals comparing Sacubitril and Valsartan versus Enalapril across multiple subgroups, including age, gender, weight, race, region, NYHA class, kidney function, diabetes status, blood pressure, ejection fraction, and prior treatment use. The plot shows the relative effect sizes and confidence intervals for each subgroup with a vertical line at hazard ratio 1 for reference.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.